We are thrilled to advance CGB-500, a novel and innovative option for localized treatment of AD, one more step closer to helping patients! https://lnkd.in/g7VuYkqg
CAGE Bio Inc.
生物技术
San Carlos，California 1,526 位关注者
Transforming ionic liquids into healthcare solutions
关于我们
CAGE Bio Inc. is a privately-held clinical-stage company exploiting its proprietary deep eutectic ionic liquid platform to develop novel products for dermatology, inflammation, and immunology
- 所属行业
- 生物技术
- 规模
- 2-10 人
- 总部
- San Carlos，California
- 类型
- 私人持股
- 创立
- 2018
地点
CAGE Bio Inc.员工
-
Samir Mitragotri
Professor @ Harvard University | Hiller Professor of Bioengineering | Hansjorg Wyss Professor of Biologically Inspired Engineering | Wyss Institute
-
Drew Sturtevant, Ph.D.
Scientist
-
Marina Shevachman
Sr. Director, Product Development at CAGE Bio, Inc
-
Jansen Loeb
Rubrik - Helping Organizations Assure Cyber Recovery
动态
-
?? Transforming Medical Dermatology with Smart Drug Design and Delivery Science ?? Hear from a global authority in drug delivery science—our co-founder,?Prof. Samir Mitragotri—as he explores how innovative approaches in drug design and delivery are revolutionizing medical dermatology. Discover how?ionic liquids?and next-generation topical therapeutics are paving the way for more effective treatments: - https://lnkd.in/gpHFmvRb - https://lnkd.in/geWF7hjN Join us in reimagining the future of dermatological care!
-
We are thrilled to advance CGB-500, a novel and innovative option for localized treatment of AD, one more step closer to helping patients! https://lnkd.in/g7VuYkqg